Non-Apoptotic Caspase-3 Activation Mediates Early Synaptic Dysfunction of Indirect Pathway Neurons in the Parkinsonian Striatum.
Tim FieblingerChang LiElena EspaM Angela CenciPublished in: International journal of molecular sciences (2022)
Non-apoptotic caspase-3 activation is critically involved in dendritic spine loss and synaptic dysfunction in Alzheimer's disease. It is, however, not known whether caspase-3 plays similar roles in other pathologies. Using a mouse model of clinically manifest Parkinson's disease, we provide the first evidence that caspase-3 is transiently activated in the striatum shortly after the degeneration of nigrostriatal dopaminergic projections. This caspase-3 activation concurs with a rapid loss of dendritic spines and deficits in synaptic long-term depression (LTD) in striatal projection neurons forming the indirect pathway. Interestingly, systemic treatment with a caspase inhibitor prevents both the spine pruning and the deficit of indirect pathway LTD without interfering with the ongoing dopaminergic degeneration. Taken together, our data identify transient and non-apoptotic caspase activation as a critical event in the early plastic changes of indirect pathway neurons following dopamine denervation.
Keyphrases
- cell death
- induced apoptosis
- mouse model
- prefrontal cortex
- spinal cord
- oxidative stress
- traumatic brain injury
- depressive symptoms
- endoplasmic reticulum stress
- computed tomography
- magnetic resonance
- metabolic syndrome
- signaling pathway
- anti inflammatory
- sleep quality
- cerebral ischemia
- sensitive detection
- data analysis